TGF-β controls stromal telomere length through epigenetic modifications
Authors:
- 24 September 2022
- journal article
- research article
- Published by Springer Nature in 3 Biotech
- Vol. 12 (11) , 1-14
Abstract
No abstract availableKeywords
All Related Versions
This publication has 67 references indexed in Scilit:
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Role for Stromal Heterogeneity in Prostate TumorigenesisCancer Research, 2011
- Lifestyle impacts on the aging‐associated expression of biomarkers of DNA damage and telomere dysfunction in human bloodAging Cell, 2010
- Telomerase as an Important Target of Androgen Signaling Blockade for Prostate Cancer TreatmentMolecular Cancer Therapeutics, 2010
- Notch and Transforming Growth Factor-β (TGFβ) Signaling Pathways Cooperatively Regulate Vascular Smooth Muscle Cell DifferentiationJournal of Biological Chemistry, 2010
- A ‘higher order’ of telomere regulation: telomere heterochromatin and telomeric RNAsThe EMBO Journal, 2009
- The Canonical Notch Signaling Pathway: Unfolding the Activation MechanismCell, 2009
- Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and diseaseProceedings of the National Academy of Sciences, 2008
- Stromal Transforming Growth Factor-β Signaling Mediates Prostatic Response to Androgen Ablation by Paracrine Wnt ActivityCancer Research, 2008
- Telomeres shorten during ageing of human fibroblastsNature, 1990